T4/T3 Therapy for Hypothyroidism

This trial explores whether combining two thyroid medications, levothyroxine (LT4) and liothyronine (LT3), is more effective than levothyroxine with a placebo for individuals with hypothyroidism who continue to experience symptoms despite normal TSH levels. The researchers aim to determine if adding LT3 can alleviate these persistent symptoms. Suitable participants have managed hypothyroidism for at least six months, maintain a stable LT4 dose, and still experience symptoms like fatigue or depression. As a Phase 2 trial, this research focuses on assessing the treatment's effectiveness in an initial, smaller group of participants.

You may need to stop taking certain medications to join the trial. Specifically, you cannot use LT3, thyroid extracts, Tirosint, amiodarone, lithium, methimazole, propylthiouracil, high doses of corticosteroids, immunotherapy, tyrosine kinase inhibitors, interferon, or biotin supplements.

Studies have shown that combining levothyroxine (LT4) and liothyronine (LT3) is generally safe for people with hypothyroidism. One study with patients who underwent thyroid surgery found this treatment well-tolerated. However, some research raises safety questions about adding liothyronine (T3) to treatment, citing concerns about side effects like thyrotoxicosis, which occurs when excess thyroid hormone is present in the body.

Researchers are excited about the T4/T3 therapy for hypothyroidism because it combines levothyroxine (T4) with liothyronine (T3), potentially offering a more balanced hormone replacement. Unlike the standard treatment, which typically involves levothyroxine alone, this combination aims to mimic the body's natural thyroid hormone production more closely. This could lead to improved symptom relief for patients who don't fully benefit from T4-only therapy. By addressing both hormones, the therapy might provide a more comprehensive approach to managing hypothyroidism.

This trial will compare the effectiveness of two treatment approaches for hypothyroidism: a combination of levothyroxine (LT4) and liothyronine (LT3) versus LT4 with a placebo. Research has shown that combining these two thyroid medications does not consistently offer more benefits than using LT4 alone for treating hypothyroidism. Studies from fourteen clinical trials indicate no significant improvement in quality of life or symptom relief with the combination therapy. Additionally, important measures like thyroid-stimulating hormone (TSH) levels remain similar whether patients use the combination or just LT4. However, some patients report feeling better with both medications, suggesting it might help certain individuals. Overall, the evidence does not strongly support a significant advantage of using LT4 and LT3 together for most people with hypothyroidism.³⁵⁶⁷⁸